Kavar Capital Partners Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Kavar Capital Partners Group's LLY Position: Q2 2026 in Review
Kavar Capital Partners Group increased its Eli Lilly (LLY) stake by 43% in Q2 2026, buying an estimated $1.72M and bringing the position to 5,587 shares worth $6.7M. The position accounts for 0.83% of the portfolio, ranked #37.
Kavar Capital Partners Group first reported a position in LLY in Q2 2015 and has held it in 23 quarters since. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Kavar Capital Partners Group held 5,587 shares of Eli Lilly worth $6.7M as of Q2 2026.
- Kavar Capital Partners Group bought 1,683 Eli Lilly shares in Q2 2026, an estimated $1.72M.
- Eli Lilly made up 0.83% of Kavar Capital Partners Group's portfolio in Q2 2026, its #37 holding.
- Kavar Capital Partners Group first reported a position in Eli Lilly in Q2 2015 and has held it in 23 quarters since.
- 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Kavar Capital Partners Group's 13F filing for Q2 2026, filed 20 Jul 2026.